RIPK3 and colorectal cancer: Transient (Fig. 4a) and stable (Fig. 4b) overexpression of TRAF6 in colorectal cancer cells significantly decreased the protein levels of RIPK1 and p-RIPK1 as well as downstream p-RIPK3 and p-MLKL produce inhibition.